Canandaigua National Bank & Trust Co. decreased its holdings in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 1.6% during the 4th quarter, Holdings Channel reports. The firm owned 81,533 shares of the company’s stock after selling 1,295 shares during the quarter. Procter & Gamble comprises 1.3% of Canandaigua National Bank & Trust Co.’s holdings, making the stock its 13th largest position. Canandaigua National Bank & Trust Co.’s holdings in Procter & Gamble were worth $13,669,000 at the end of the most recent quarter.
A number of other hedge funds have also added to or reduced their stakes in the business. Concurrent Investment Advisors LLC increased its position in shares of Procter & Gamble by 4.5% during the third quarter. Concurrent Investment Advisors LLC now owns 94,109 shares of the company’s stock worth $16,300,000 after acquiring an additional 4,035 shares in the last quarter. Copley Financial Group Inc. purchased a new stake in shares of Procter & Gamble in the third quarter worth approximately $668,000. Synovus Financial Corp boosted its position in shares of Procter & Gamble by 3.4% during the third quarter. Synovus Financial Corp now owns 185,134 shares of the company’s stock valued at $32,065,000 after buying an additional 6,077 shares during the last quarter. Radnor Capital Management LLC bought a new stake in Procter & Gamble during the third quarter worth $5,705,000. Finally, Welch Group LLC lifted its stake in Procter & Gamble by 0.9% during the 3rd quarter. Welch Group LLC now owns 323,870 shares of the company’s stock valued at $56,094,000 after acquiring an additional 2,990 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Trading Down 2.7 %
Shares of PG traded down $4.52 during mid-day trading on Monday, reaching $160.61. The company’s stock had a trading volume of 8,538,484 shares, compared to its average volume of 5,385,503. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43. The company’s fifty day moving average price is $170.21 and its two-hundred day moving average price is $169.85. The stock has a market cap of $378.24 billion, a PE ratio of 27.69, a P/E/G ratio of 3.70 and a beta of 0.45.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.51%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.31%.
Analyst Upgrades and Downgrades
Several analysts have recently issued reports on the stock. Evercore ISI upped their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday, October 21st. Wells Fargo & Company raised their target price on Procter & Gamble from $188.00 to $190.00 and gave the stock an “overweight” rating in a research report on Friday, November 22nd. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price on the stock. DA Davidson reiterated a “buy” rating and issued a $209.00 price target on shares of Procter & Gamble in a research report on Friday, December 27th. Finally, Hsbc Global Res raised Procter & Gamble to a “strong-buy” rating in a report on Friday, October 4th. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to data from MarketBeat, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $180.45.
View Our Latest Stock Analysis on PG
Insider Transactions at Procter & Gamble
In related news, insider Balaji Purushothaman sold 12,800 shares of the business’s stock in a transaction dated Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the transaction, the insider now owns 11,566 shares in the company, valued at $1,954,538.34. The trade was a 52.53 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 47,847 shares of the business’s stock in a transaction that occurred on Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total value of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares in the company, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 75,439 shares of company stock worth $13,317,460. Insiders own 0.18% of the company’s stock.
About Procter & Gamble
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- What Do S&P 500 Stocks Tell Investors About the Market?
- Build-Your-Bowl Battle: CAVA, Chipotle, and Sweetgreen Face Off
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Insiders Are Loading Up: 3 Key Stock Picks for Investors
- Trading Halts Explained
- How Cigna Remains at the Top of the Health Insurance Food Chain
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.